CARLE CANCER CENTER COMMUNITY CLINICAL ONCOLOGY PROGRAM

卡尔癌症中心社区临床肿瘤学项目

• 批准号: 2088871
• 负责人: ALAN K HATFIELD
• 金额: $ 32.17万
• 依托单位: CARLE FOUNDATION
• 依托单位国家: 美国
• 财政年份: 1990
• 资助国家: 美国
• 起止时间: 1990-06-01 至 1998-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2088871
• 关键词: breast neoplasm /cancer diagnosis; breast neoplasms; cancer prevention; cancer rehabilitation /care; clinical trials; community health services; cooperative study; female; human subject; human therapy evaluation; neoplasm /cancer chemotherapy; neoplasm /cancer diagnosis; neoplasm /cancer education; neoplasm /cancer therapy

In response to RFA CA-92-15 Community Clinical Oncology Program, National Cancer Institute, the Carle Cancer Center CCOP, Urbana, Illinois, is making application to continue to be designated as a CCOP in East Central Illinois. As the 12th largest private medical group practice in the United States, with over 250 physicians, the Carle Clinic Association has a fully developed community cancer center program which has been involved in national clinical trials research since 1976. Joining Carle in this CCOP application as a component institution will be the Suburban Heights Medical Center of Chicago Heights, Illinois, a physician group practice of more than 60 physicians. Also joining Carle as affiliate institutions are the Carbondale Clinic, Carbondale, Illinois, a 35 physician group practice located in southern Illinois, and a private physician group practice in Joliet, Illinois. The combined Carle Cancer Center CCOP provides services to cancer patients from a large, nearly contiguous catchment area covering areas of east central, northeast and southern Illinois. The headquarters for the CCOP will be located at the Carle Cancer Center with all randomization, administrative matters and quality assurance programs being based there. The CCOPs primary research base is the North Central Cancer Treatment group (NCCTG), headquartered at the Mayo Clinic. Other research base affiliations will be with the Eastern Cooperative Oncology Group (ECOG) and the National Surgical Adjuvant Breast and Bowel Project (NSABP). The Illinois Cancer Center (ICC) has been a research base but will lose funding effective 12/92. CCOP dedicated research staff personnel and nurse clinicians will assist the investigating physicians in placing patients on clinical cancer research protocols resulting in 155 cancer treatment credits and 230 cancer control credits annually. One hundred and eighty cancer control credits will come from the Breast Cancer Prevention Trial (NSABP Protocol P-1). The goal of the Carle Cancer Center CCOP is to facilitate transfer of modern methods of cancer treatment, control and prevention to the citizens and health professionals of the proposed service area. It is the Carle Cancer Center CCOPs continued belief that a community cancer center program should maintain participation in clinical research protocols, public and professional education and cancer prevention and detection as well as providing the highest standards of clinical cancer care.

针对RFA CA-92-15社区临床肿瘤学项目，国家 癌症研究所，卡尔癌症中心CCOP，厄巴纳，伊利诺伊州，是 申请继续被指定为东中部的CCOP 伊利诺 作为美国第12大私人医疗集团， 美国卡尔诊所协会拥有250多名医生， 一个完善的社区癌症中心计划， 自1976年以来，国家临床试验研究。 加入卡尔的行列 CCOP应用程序作为一个组成部分的机构将是郊区高地 伊利诺伊州芝加哥高地医疗中心，一个医师团体实践 超过60名医生。 加入Carle成为附属机构 是伊利诺伊州卡本代尔的卡本代尔诊所， 位于伊利诺斯州南部的一家私人诊所， 在伊利诺伊州的乔利埃特执业。 卡尔癌症中心CCOP 为癌症患者提供服务， 涵盖中东部、东北部及南部地区的集水区 伊利诺 CCOP的总部将设在卡尔癌症中心 所有随机化、行政事务和质量保证 节目就在那里。 CCOPs的主要研究基地是北方 中央癌症治疗小组（NCCTG），总部设在马约诊所。 其他研究基地隶属关系将与东部合作社 肿瘤组（ECOG）和国家外科辅助乳腺和肠道 项目（NSABP）。 伊利诺伊州癌症中心（ICC）进行了一项研究， #21412;，但将于1992年12月1日起停止融资。 CCOP专门研究 工作人员和临床护士将协助调查 医生将患者置于临床癌症研究方案中 导致155个癌症治疗学分和230个癌症控制学分 每年。 一百八十个癌症控制学分将来自 乳腺癌预防试验（NSABP方案P-1）。 卡尔癌症中心CCOP的目标是促进转移 现代癌症治疗、控制和预防方法 建议服务区的公民和卫生专业人员。 是 卡尔癌症中心CCOPs继续相信， 中心计划应保持对临床研究的参与 议定书、公共和专业教育以及癌症预防， 检测以及提供最高标准的临床癌症 在乎